At Trustlife Therapeutics, we bring together a unique blend of expertise in systems biology and artificial intelligence—combining years of academic research with cutting-edge computational approaches. Our London office serves as the technological headquarters and central hub for our AI-driven efforts. The UK team featured includes 8 highly qualified experts in software development and systems biology, who work collaboratively to turn complex biological data into breakthrough therapies.
Dr. Adil Mardinoglu is a professor of Systems Biology at King's College London and a professor at KTH Royal Institute of Technology in Stockholm. Between 2019-2020, he served as the President of TUSEB (Turkish Health Institute) affiliated to the Ministry of Health of the Republic of Turkey. With a background in electronics engineering and a PhD in Computerized Medicine, he specializes in metabolic modeling, systems biology, and the integration of multi-omics data for drug discovery and precision medicine.
Group Leader in Quantitative Systems Biology & AI, Senior Lecturer in Systems Biology at King's College London
Docent in Systems Medicine and Group Leader at Science for Life Laboratory, Senior Lecturer at King's College London